Space Economy 2026: $ASTS vs $RKLB vs $SPCE vs $FJET — Four Business Models Compared

Executive summary

The publicly traded “space economy” is not a single, homogeneous theme: within the same narrative live radically different business models, with cash, risk and maturity profiles that sit at opposite ends of the spectrum. This report compares four names that represent four distinct bets on space: AST SpaceMobile ($ASTS), Rocket Lab ($RKLB), Virgin Galactic ($SPCE) and Starfighters Space ($FJET).

The 2026 backdrop changed materially with the record SpaceX IPO, which brought enormous capital and media attention back to the sector but also triggered a repositioning: after the initial enthusiasm, several “space” names saw a sell-off, with brokerage houses openly discussing bearish trades on the group. In this climate, the difference between companies with real revenue and a solid cash position and those still pre-revenue becomes decisive.

Rocket Lab is the most mature name here: record quarterly revenue (about $200 million in Q1 2026, +63.5% year-over-year), a $2.2 billion backlog and the Neutron rocket due to debut by the end of 2026. AST SpaceMobile is the “infrastructure” bet on satellite-to-phone: a huge cash pile (about $3.5 billion) but still minimal revenue and a model yet to be proven at commercial scale. Virgin Galactic is the suborbital tourism story, with its new Delta-class vehicles coming but a fragile cash position and a “going concern” flag in its 10-K. Starfighters Space is the smallest, most speculative name: pre-revenue, built on a fleet of F-104 supersonic jets and the STARLAUNCH air-launch platform.

The purpose of this article is strictly informational: to compare business models, verified numbers, catalysts and risks, and to outline illustrative bull and bear sector scenarios — without making any buy or sell recommendation.

Quick snapshot (as of 26 June 2026)

The backdrop: space economy after the SpaceX IPO

For years, a “pure” space investment was hard to find for retail investors: listed names were few and often the legacy of disappointing SPACs. In 2026 the SpaceX listing changed the perception of the sector, attracting capital and fresh analyst coverage. The effect, however, cut both ways: after the initial euphoria, several space names (including $ASTS, $RKLB, $SPCE and others) saw profit-taking, and some investment houses began openly discussing bearish “betting against space” trades.

Against this backdrop, the four stocks analyzed here let you read the sector along two axes: revenue maturity (from Rocket Lab, with hundreds of millions in revenue, to Starfighters, still pre-revenue) and type of exposure (telecom infrastructure, space access, experience/tourism, testing services). They are four different ways to “buy space,” with very different risk levels.

The four business models compared

$ASTS — AST SpaceMobile: a cellular network from space

AST SpaceMobile aims to build the first cellular broadband network accessible directly from standard smartphones via satellites (the “BlueBirds”), in partnership with mobile operators such as AT&T, Verizon and Vodafone, plus the US government. It is a highly capital-intensive infrastructure bet: in February 2026 the company raised about $1.075 billion via 10-year convertible notes with a 2.250% coupon, bringing total cash to roughly $3.5 billion (including $429.3 million of restricted cash) at the end of March 2026. The current weak spot is revenue: Q1 2026 came in at $14.7 million (below expectations), while full-year 2026 guidance is $150–200 million, driven by network partners and government contracts.

$RKLB — Rocket Lab: the most mature launch company in the group

Rocket Lab has the strongest fundamentals of the four. In Q1 2026 it posted record revenue of about $200.3 million (+63.5% year-over-year), a $2.2 billion backlog (+20% quarter-over-quarter) and a record GAAP gross margin of 38.2%. Cash at quarter-end was $1.48 billion, with over $2 billion in total liquidity. The model combines the small Electron launcher (50+ successful launches), the Space Systems segment (satellites and components) and, above all, the medium-lift Neutron rocket, whose debut is expected by the end of 2026 and which has already secured launch contracts before flying.

$SPCE — Virgin Galactic: suborbital tourism tested by the balance sheet

Virgin Galactic sells the suborbital flight experience to tourists and for scientific research. After pausing commercial flights to focus on its new Delta-class vehicles — designed for more frequent flights (high-frequency operations once the Delta fleet is built and cleared) — the company said it remains on track for Delta-class flight testing in Q3 2026 and its first spaceflight in Q4 2026. The crux is financial: cash, cash equivalents and marketable securities were $251 million as of 31 March 2026, with negative free cash flow of about $78 million in Q1 2026 and a “going concern” flag in the 10-K. It is the most binary story from a balance-sheet standpoint.

$FJET — Starfighters Space: supersonic testing and air-launch

Starfighters Space is the smallest, most speculative name. Based at NASA’s Kennedy Space Center, it operates the only commercial fleet of Lockheed F-104 supersonic jets, offering Mach 2+ flight testing, pilot training and air-launch services. The company is still pre-revenue: Q1 2026 showed nil revenue, operating expenses of about $4.05 million, a net loss of about $4.27 million, and cash plus restricted cash of $2.14 million at March 31, 2026. In May 2026 it announced a $17.5 million strategic equity investment to support expansion and the STARLAUNCH air-launch platform. The stock remains extremely volatile, especially after the December 2025 spike and June 2026 pullback.

Comparative financial position

Catalysts and timeline

• $$RKLB — Neutron debut (Q4 2026 target): first flight of the medium-lift rocket, with contracts already signed pre-launch. The most anticipated catalyst in the group.
• $$SPCE — Delta-class flights: Delta-class flight testing remains targeted for Q3 2026, with the first spaceflight targeted for Q4 2026; commercial service start remains the next major milestone.
• $$ASTS — Infrastructure ramp: deploying BlueBird gateways and satellites, activating services with mobile partners and US government contracts; the FY26 revenue guidance ($150–200M) is the execution thermometer.
• $$FJET — STARLAUNCH and partnerships: progress on the air-launch platform and potential hypersonic testing deals; deployment of the capital raised in May 2026.
• Sector — SpaceX effect: post-IPO sentiment around SpaceX remains a cross-cutting factor that can amplify moves across the whole group.

Illustrative sector scenarios (not recommendations)

Risks and red flags

• Execution/technology risk: launches, flights and space deployments are inherently binary; delays or technical failures can push revenue out by quarters or years.
• Dilution risk: $SPCE and $FJET depend on capital markets; raises after negative catalysts can be highly dilutive. $ASTS has already issued sizable convertibles.
• Valuation risk: some names (notably $ASTS and $RKLB) trade at high multiples relative to current revenue; a shift in sentiment can amplify corrections.
• Going concern ($SPCE): the 10-K flag signals uncertainty about continuity without new capital.
• Liquidity and volatility ($FJET): pre-revenue micro-cap with extreme swings (recent trading range remains extremely volatile after the December 2025 spike and June 2026 pullback).
• Sector/sentiment risk: the SpaceX effect and bearish sector trades can move all names regardless of individual fundamentals.

Bottom line

Side by side, the four stocks show how heterogeneous the “space economy” really is. Rocket Lab is the most mature profile by revenue, backlog and cash, with a clear catalyst (Neutron). AST SpaceMobile is the highest-capital, highest-cash infrastructure bet, but with revenue still to be built. Virgin Galactic is the story most tied to a return to flight and balance-sheet resilience. Starfighters Space is the smallest, most speculative option, still pre-revenue. Each answers a different risk profile and time horizon: the point of this comparison is not to crown a “winner,” but to clarify exactly what you are buying in each of the four cases.